Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simeng Lu

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Theranostics|February 16, 2026
A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activationZhenzhen Yin, Simeng Lu, Limeng Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated PainZhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma ModelSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Nature Communications|February 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing lossSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Theranostics|February 16, 2026
A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activationZhenzhen Yin, Simeng Lu, Limeng Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated PainZhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma ModelSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Nature Communications|February 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing lossSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.
Pageof 3